| transmembrane transport | GO:0055085 | 412 | 0.780 | Mouse Rat |
| cation transport | GO:0006812 | 399 | 0.707 | Mouse Rat |
| ion transmembrane transport | GO:0034220 | 361 | 0.648 | Mouse Rat |
| lymphocyte differentiation | GO:0030098 | 242 | 0.605 | |
| synaptic transmission | GO:0007268 | 329 | 0.475 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.474 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.397 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.379 | |
| regulation of system process | GO:0044057 | 200 | 0.331 | |
| response to radiation | GO:0009314 | 165 | 0.310 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.279 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.262 | |
| cation homeostasis | GO:0055080 | 212 | 0.260 | |
| muscle system process | GO:0003012 | 141 | 0.248 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.238 | |
| heart morphogenesis | GO:0003007 | 178 | 0.236 | |
| cytokine production | GO:0001816 | 319 | 0.227 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.212 | |
| membrane depolarization | GO:0051899 | 64 | 0.210 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.209 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.208 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.204 | |
| t cell differentiation | GO:0030217 | 174 | 0.202 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.195 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.192 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.189 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.185 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.184 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.181 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.178 | |
| stem cell development | GO:0048864 | 219 | 0.177 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.172 | Mouse Rat |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.171 | |
| calcium ion transport | GO:0006816 | 159 | 0.171 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 48 | 0.168 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.167 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.166 | |
| circulatory system process | GO:0003013 | 197 | 0.166 | |
| cell adhesion | GO:0007155 | 329 | 0.164 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.163 | |
| inflammatory response | GO:0006954 | 244 | 0.161 | |
| regulation of cell size | GO:0008361 | 72 | 0.160 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.159 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.156 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.156 | |
| blood circulation | GO:0008015 | 195 | 0.154 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.152 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.151 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.150 | |
| angiogenesis | GO:0001525 | 201 | 0.148 | |
| amine metabolic process | GO:0009308 | 45 | 0.146 | |
| regulation of cell activation | GO:0050865 | 289 | 0.143 | |
| protein localization to membrane | GO:0072657 | 108 | 0.140 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.138 | |
| visual behavior | GO:0007632 | 45 | 0.138 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.133 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.133 | |
| muscle contraction | GO:0006936 | 101 | 0.130 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.130 | |
| action potential | GO:0001508 | 78 | 0.130 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.126 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.126 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.125 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.125 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.122 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.122 | |
| membrane organization | GO:0061024 | 245 | 0.122 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.122 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.120 | |
| regulation of cell migration | GO:0030334 | 219 | 0.119 | |
| regulation of protein transport | GO:0051223 | 163 | 0.118 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.118 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.116 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.116 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.115 | |
| negative regulation of bone trabecula formation | GO:1900155 | 1 | 0.114 | |
| regulation of ion transport | GO:0043269 | 215 | 0.111 | |
| camera type eye development | GO:0043010 | 266 | 0.111 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.110 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.109 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.107 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.107 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.106 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.106 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.105 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.104 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.104 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.102 | |
| response to light stimulus | GO:0009416 | 135 | 0.102 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.100 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.100 | |
| digestive system development | GO:0055123 | 200 | 0.099 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.098 | |
| gas homeostasis | GO:0033483 | 3 | 0.098 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.098 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.097 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.096 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.095 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.095 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.094 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.094 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.093 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.093 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.093 | |
| neuronal action potential | GO:0019228 | 54 | 0.091 | |
| ossification | GO:0001503 | 216 | 0.091 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.091 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.091 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.090 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.089 | |
| learning | GO:0007612 | 98 | 0.089 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.088 | |
| maintenance of cell number | GO:0098727 | 3 | 0.086 | |
| epidermis development | GO:0008544 | 187 | 0.086 | |
| skeletal system development | GO:0001501 | 356 | 0.086 | |
| heart contraction | GO:0060047 | 93 | 0.085 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.085 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.085 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.085 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.084 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.084 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.084 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.084 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.083 | |
| synapse organization | GO:0050808 | 125 | 0.083 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.083 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.083 | |
| lung development | GO:0030324 | 164 | 0.082 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.082 | |
| long term synaptic potentiation | GO:0060291 | 25 | 0.082 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.082 | |
| skin development | GO:0043588 | 220 | 0.081 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.081 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.081 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.081 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.081 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.080 | |
| membrane lipid biosynthetic process | GO:0046467 | 32 | 0.080 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.079 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.079 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.077 | |
| regulation of tube size | GO:0035150 | 57 | 0.077 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.077 | |
| learning or memory | GO:0007611 | 148 | 0.077 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 3 | 0.077 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.076 | |
| response to nutrient levels | GO:0031667 | 109 | 0.075 | |
| locomotory behavior | GO:0007626 | 195 | 0.075 | |
| stem cell differentiation | GO:0048863 | 268 | 0.075 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.075 | |
| regulation of secretion | GO:0051046 | 274 | 0.075 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.074 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.074 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.074 | |
| t cell activation | GO:0042110 | 289 | 0.074 | |
| regulation of retina development in camera type eye | GO:1902866 | 3 | 0.074 | |
| cell growth | GO:0016049 | 130 | 0.072 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.072 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.072 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.072 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.072 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.072 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.071 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.071 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.071 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.071 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.070 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.070 | |
| regulation of heart rate | GO:0002027 | 36 | 0.069 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.069 | |
| b cell activation | GO:0042113 | 161 | 0.068 | |
| regulation of neurotransmitter secretion | GO:0046928 | 29 | 0.068 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.068 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.067 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.067 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.067 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.067 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.067 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.066 | |
| cellular homeostasis | GO:0019725 | 240 | 0.066 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.066 | |
| organelle assembly | GO:0070925 | 177 | 0.065 | |
| striated muscle contraction | GO:0006941 | 45 | 0.065 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.064 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.064 | |
| regulation of protein localization | GO:0032880 | 231 | 0.063 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.063 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.063 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.062 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.062 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.062 | |
| positive regulation of heart rate | GO:0010460 | 10 | 0.061 | |
| regulation of anagen | GO:0051884 | 1 | 0.061 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.061 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.061 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.060 | |
| gland development | GO:0048732 | 330 | 0.060 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.060 | |
| developmental cell growth | GO:0048588 | 84 | 0.060 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.060 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.059 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.059 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.059 | |
| cerebellar cortex formation | GO:0021697 | 22 | 0.058 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.058 | |
| regulation of neuron death | GO:1901214 | 134 | 0.058 | |
| neuromuscular process | GO:0050905 | 99 | 0.058 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.057 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.057 | |
| digestive tract development | GO:0048565 | 190 | 0.056 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.056 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.056 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.056 | |
| limb morphogenesis | GO:0035108 | 149 | 0.056 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.055 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.055 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.055 | |
| visual learning | GO:0008542 | 44 | 0.055 | |
| spemann organizer formation | GO:0060061 | 2 | 0.054 | |
| b cell differentiation | GO:0030183 | 78 | 0.054 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.054 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.054 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.054 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.053 | |
| somitogenesis | GO:0001756 | 69 | 0.053 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.053 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.053 | |
| chemotaxis | GO:0006935 | 247 | 0.053 | |
| striated muscle cell development | GO:0055002 | 125 | 0.053 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.052 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.052 | |
| endocytosis | GO:0006897 | 168 | 0.051 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.051 | |
| regionalization | GO:0003002 | 337 | 0.050 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.050 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.050 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.050 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.050 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.050 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.049 | |
| nephric duct formation | GO:0072179 | 4 | 0.049 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.049 | |
| regulation of circadian sleep wake cycle | GO:0042749 | 3 | 0.049 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.048 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.048 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.048 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.048 | |
| response to oxygen levels | GO:0070482 | 62 | 0.047 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.047 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.047 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.047 | |
| protein secretion | GO:0009306 | 111 | 0.046 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.046 | |
| cognition | GO:0050890 | 149 | 0.046 | |
| digestion | GO:0007586 | 40 | 0.046 | |
| regulation of cell motility | GO:2000145 | 236 | 0.046 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.046 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.046 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.046 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.046 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.046 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.045 | |
| norepinephrine secretion | GO:0048243 | 2 | 0.045 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.045 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.045 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.044 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.044 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.044 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.044 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.044 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.044 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.044 | |
| establishment of anatomical structure orientation | GO:0048560 | 1 | 0.044 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.044 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.044 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.044 | |
| oxidation reduction process | GO:0055114 | 342 | 0.044 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.044 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.044 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.044 | |
| neuron death | GO:0070997 | 154 | 0.044 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.043 | |
| amide transport | GO:0042886 | 138 | 0.043 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.043 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.043 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.043 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.043 | |
| adaptive immune response | GO:0002250 | 155 | 0.043 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.043 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.043 | |
| sa node cell to atrial cardiac muscle cell signalling | GO:0086018 | 4 | 0.042 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.042 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.042 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.042 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.042 | |
| histone modification | GO:0016570 | 159 | 0.042 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.042 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.041 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.041 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.041 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.041 | |
| ear development | GO:0043583 | 200 | 0.041 | |
| lipid transport | GO:0006869 | 98 | 0.041 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.041 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.040 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.040 | |
| cardiac septum development | GO:0003279 | 59 | 0.040 | |
| regulation of excitatory postsynaptic membrane potential | GO:0060079 | 41 | 0.040 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.040 | |
| regulation of organ growth | GO:0046620 | 61 | 0.040 | |
| phosphatidylethanolamine metabolic process | GO:0046337 | 2 | 0.039 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.039 | |
| visual perception | GO:0007601 | 52 | 0.039 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.039 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.039 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.039 | |
| multi organism behavior | GO:0051705 | 62 | 0.039 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.039 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.039 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.039 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.039 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.038 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.038 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.038 | |
| l glutamate import into cell | GO:1990123 | 3 | 0.037 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.037 | |
| wound healing | GO:0042060 | 157 | 0.037 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.037 | |
| positive regulation of glycolytic process | GO:0045821 | 4 | 0.037 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.037 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.036 | |
| monoamine transport | GO:0015844 | 33 | 0.036 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.036 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.036 | |
| response to steroid hormone | GO:0048545 | 56 | 0.036 | |
| regulation of engulfment of apoptotic cell | GO:1901074 | 2 | 0.036 | |
| regulation of synapse assembly | GO:0051963 | 29 | 0.036 | |
| associative learning | GO:0008306 | 61 | 0.036 | |
| positive regulation of rho gtpase activity | GO:0032321 | 41 | 0.036 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.036 | |
| tissue remodeling | GO:0048771 | 102 | 0.036 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.035 | |
| endothelial cell proliferation | GO:0001935 | 27 | 0.035 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.035 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.035 | |
| cardiac chamber development | GO:0003205 | 108 | 0.035 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.035 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.034 | |
| organic anion transport | GO:0015711 | 137 | 0.034 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.034 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.034 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.034 | |
| sodium ion transport | GO:0006814 | 73 | 0.034 | |
| pallium development | GO:0021543 | 120 | 0.034 | |
| microtubule based process | GO:0007017 | 236 | 0.034 | |
| sperm ejaculation | GO:0042713 | 1 | 0.034 | |
| submandibular salivary gland formation | GO:0060661 | 1 | 0.034 | |
| sensory perception | GO:0007600 | 245 | 0.033 | |
| positive regulation of growth | GO:0045927 | 104 | 0.033 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.033 | |
| multicellular organismal reproductive behavior | GO:0033057 | 23 | 0.033 | |
| circadian rhythm | GO:0007623 | 114 | 0.033 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.033 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.033 | |
| tube formation | GO:0035148 | 140 | 0.033 | |
| conditioned taste aversion | GO:0001661 | 4 | 0.033 | |
| cell division | GO:0051301 | 120 | 0.032 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.032 | |
| establishment of planar polarity involved in neural tube closure | GO:0090177 | 15 | 0.032 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.032 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.032 | |
| response to oxidative stress | GO:0006979 | 123 | 0.032 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.032 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.032 | |
| alpha amino 3 hydroxy 5 methyl 4 isoxazole propionate selective glutamate receptor clustering | GO:0097113 | 3 | 0.032 | |
| positive regulation of heart contraction | GO:0045823 | 14 | 0.032 | |
| regulation of cell growth | GO:0001558 | 91 | 0.032 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.032 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.032 | |
| muscle cell development | GO:0055001 | 133 | 0.032 | |
| nuclear division | GO:0000280 | 158 | 0.032 | |
| renal vesicle induction | GO:0072034 | 3 | 0.032 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.032 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.032 | |
| organ growth | GO:0035265 | 117 | 0.031 | |
| regulation of sodium ion transport | GO:0002028 | 29 | 0.031 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.031 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.031 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.031 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.031 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.031 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.031 | |
| male sex differentiation | GO:0046661 | 109 | 0.031 | |
| regulation of interleukin 1 production | GO:0032652 | 26 | 0.031 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.031 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.030 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.030 | |
| phosphatidylethanolamine biosynthetic process | GO:0006646 | 2 | 0.030 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.030 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.030 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.030 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.030 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.030 | |
| acetylcholine transport | GO:0015870 | 2 | 0.030 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.030 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.030 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.030 | |
| response to inactivity | GO:0014854 | 4 | 0.030 | |
| mapk cascade | GO:0000165 | 281 | 0.030 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.030 | |
| sensory perception of pain | GO:0019233 | 47 | 0.030 | |
| regulation of ossification | GO:0030278 | 112 | 0.030 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.029 | |
| neuron projection guidance | GO:0097485 | 141 | 0.029 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.029 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.029 | |
| hair follicle development | GO:0001942 | 85 | 0.029 | |
| rhythmic process | GO:0048511 | 174 | 0.029 | |
| regulation of cardiac muscle contraction | GO:0055117 | 21 | 0.029 | |
| acid secretion | GO:0046717 | 33 | 0.029 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.029 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 4 | 0.029 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.029 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.029 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.029 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.029 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.029 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.028 | |
| hormone metabolic process | GO:0042445 | 86 | 0.028 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.028 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.028 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.028 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.028 | |
| cerebellum development | GO:0021549 | 77 | 0.028 | |
| postsynaptic membrane organization | GO:0001941 | 18 | 0.028 | |
| memory | GO:0007613 | 58 | 0.028 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.028 | |
| positive regulation of blood pressure | GO:0045777 | 21 | 0.028 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.028 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.028 | |
| peptide transport | GO:0015833 | 133 | 0.028 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.028 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.028 | |
| regulation of the force of heart contraction | GO:0002026 | 17 | 0.028 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.028 | |
| cell cycle switching | GO:0060184 | 1 | 0.028 | |
| heart process | GO:0003015 | 94 | 0.027 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.027 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.027 | |
| male anatomical structure morphogenesis | GO:0090598 | 4 | 0.027 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.027 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.027 | |
| maintenance of location | GO:0051235 | 89 | 0.027 | |
| regulation of presynaptic membrane organization | GO:1901629 | 3 | 0.027 | |
| peptide secretion | GO:0002790 | 114 | 0.027 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.027 | |
| muscle fiber development | GO:0048747 | 76 | 0.027 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.026 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.026 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.026 | |
| positive regulation of phagocytosis engulfment | GO:0060100 | 3 | 0.026 | |
| cardiac muscle cell contraction | GO:0086003 | 7 | 0.026 | |
| b cell proliferation | GO:0042100 | 53 | 0.026 | |
| axonogenesis | GO:0007409 | 274 | 0.026 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.026 | |
| sensory perception of sound | GO:0007605 | 97 | 0.026 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.026 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.026 | |
| polarity specification of proximal distal axis | GO:0010085 | 2 | 0.026 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.026 | |
| negative regulation of stem cell maintenance | GO:1902455 | 4 | 0.026 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.025 | |
| feeding behavior | GO:0007631 | 62 | 0.025 | |
| regulation of action potential | GO:0098900 | 4 | 0.025 | |
| peptidyl threonine phosphorylation | GO:0018107 | 31 | 0.025 | |
| germline cell cycle switching mitotic to meiotic cell cycle | GO:0051729 | 1 | 0.025 | |
| regulation of striated muscle contraction | GO:0006942 | 25 | 0.025 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.025 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.025 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.025 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.025 | |
| forebrain morphogenesis | GO:0048853 | 17 | 0.025 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.025 | |
| response to peptide | GO:1901652 | 136 | 0.025 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.025 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 51 | 0.025 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.025 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.025 | |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.025 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.024 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.024 | |
| hormone secretion | GO:0046879 | 128 | 0.024 | |
